WAPNICK PAMELA (Chief Financial Officer) sold 9.0% of their position (6.26K shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $18.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/6/2024ACC: 0000950170-24-104439
Officer· Chief Financial Officer
Since Mar 2026
-6.26K
Net shares
Net seller
$18.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.26K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.26K
Price / share
$2.88
Trade value
$18.04K
% of position
9.0%
9/5/2024
69.32K→63.05K
Total
Net shares
−6.26K
Net value
-$18.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/5/2024 | S · Sale | −6.26K | $2.88 | $18.04K | 9.0% | 69.32K | 63.05K |
| Total | −6.26K | -$18.04K | ||||||
Derivative Transactions0
No derivative transactions reported